Characteristics of Lung Cancers Harboring NRAS Mutations

Схожие документы

• Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
  по: Ohashi, Kadoaki, et al.
  Опубликовано: (2012)
• Conjunctival Melanomas Harbor BRAF and NRAS Mutations–Letter
  по: Weber, Jaimie L., et al.
  Опубликовано: (2013)
• Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
  по: Paik, Paul K., et al.
  Опубликовано: (2011)
• Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium
  по: Villaruz, Liza C., et al.
  Опубликовано: (2014)
• Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
  по: Oxnard, Geoffrey R., et al.
  Опубликовано: (2010)